blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3677258

EP3677258 - USES OF CANNABIDIOL IN PREPARATION OF DRUGS FOR RESISTING AGAINST INFLUENZA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.12.2022
Database last updated on 14.06.2024
FormerThe patent has been granted
Status updated on  07.01.2022
FormerGrant of patent is intended
Status updated on  11.11.2021
FormerExamination is in progress
Status updated on  21.05.2021
FormerRequest for examination was made
Status updated on  05.06.2020
FormerThe international publication has been made
Status updated on  08.03.2019
Most recent event   Tooltip31.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 03.07.2024 [2024/27]
Applicant(s)For all designated states
Hanyi Bio-Technology Company Ltd.
No. 2613 Building 1 Jingguang Plaza
Hujialou
Chaoyang District
Beijing 100020 / CN
[2020/28]
Inventor(s)01 / ZHANG, Ke
No. 2613 Building 1
Jingguang Plaza
Hujialou
Chaoyang District
Beijing 100020 / CN
02 / TAN, Xin
No. 2613 Building 1
Jingguang Plaza
Hujialou
Chaoyang District
Beijing 100020 / CN
03 / LI, Xiangdong
No. 2613 Building 1
Jingguang Plaza
Hujialou
Chaoyang District
Beijing 100020 / CN
04 / YU, Zhaohui
No. 2613 Building 1
Jingguang Plaza
Hujialou
Chaoyang District
Beijing 100020 / CN
 [2020/28]
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2022/06]Murgitroyd & Company
Murgitroyd House
165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2020/28]Hanna Moore + Curley
Garryard House
25/26 Earlsfort Terrace
Dublin 2, D02 PX51 / IE
Application number, filing date17923262.431.08.2017
[2020/28]
WO2017CN99956
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019041239
Date:07.03.2019
Language:ZH
[2019/10]
Type: A1 Application with search report 
No.:EP3677258
Date:08.07.2020
Language:EN
[2020/28]
Type: B1 Patent specification 
No.:EP3677258
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)International search report - published on:CN07.03.2019
(Supplementary) European search report - dispatched on:EP11.08.2020
ClassificationIPC:A61K31/05, A61P29/00, A61P11/00, A61K31/13, A61K31/196, A61K31/215, A61K31/4045, A61K31/7012, A61K31/7056, A61K45/06
[2020/37]
CPC:
A61K45/06 (EP); A61K31/352 (US); A61K31/05 (EP);
A61K31/13 (EP); A61K31/196 (EP); A61K31/215 (EP);
A61K31/4045 (EP); A61K31/7012 (EP); A61K31/7056 (EP);
A61K36/73 (US); A61K9/0053 (US); A61P11/00 (EP);
A61P29/00 (EP); A61P31/16 (US); Y02A40/70 (EP) (-)
C-Set:
A61K31/05, A61K2300/00 (EP);
A61K31/13, A61K2300/00 (EP);
A61K31/196, A61K2300/00 (EP);
A61K31/215, A61K2300/00 (EP);
A61K31/4045, A61K2300/00 (EP);
A61K31/7012, A61K2300/00 (EP);
A61K31/7056, A61K2300/00 (EP)
(-)
Former IPC [2020/28]A61K31/05, A61P29/00, A61P11/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/28]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERWENDUNGEN VON CANNABIDIOL ZUR HERSTELLUNG VON ARZNEIMITTELN ZUR RESISTENZ GEGEN INFLUENZA[2020/28]
English:USES OF CANNABIDIOL IN PREPARATION OF DRUGS FOR RESISTING AGAINST INFLUENZA[2020/28]
French:UTILISATIONS DU CANNABIDIOL DANS LA PRÉPARATION DE MÉDICAMENTS POUR RÉSISTER À LA GRIPPE[2020/28]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase24.03.2020Translation filed 
24.03.2020National basic fee paid 
24.03.2020Search fee paid 
24.03.2020Designation fee(s) paid 
24.03.2020Examination fee paid 
Examination procedure24.03.2020Examination requested  [2020/28]
01.03.2021Amendment by applicant (claims and/or description)
26.05.2021Despatch of a communication from the examining division (Time limit: M02)
21.07.2021Reply to a communication from the examining division
12.11.2021Communication of intention to grant the patent
22.12.2021Fee for grant paid
22.12.2021Fee for publishing/printing paid
22.12.2021Receipt of the translation of the claim(s)
Opposition(s)10.11.2022No opposition filed within time limit [2023/03]
Fees paidRenewal fee
24.03.2020Renewal fee patent year 03
09.07.2020Renewal fee patent year 04
20.08.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.08.2017
AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
MK09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
BE31.08.2022
CH31.08.2022
IE31.08.2022
LI31.08.2022
LU31.08.2022
[2024/27]
Former [2024/24]HU31.08.2017
AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
BE31.08.2022
CH31.08.2022
IE31.08.2022
LI31.08.2022
LU31.08.2022
Former [2024/21]AL09.02.2022
AT09.02.2022
CY09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
BE31.08.2022
CH31.08.2022
IE31.08.2022
LI31.08.2022
LU31.08.2022
Former [2023/42]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
BE31.08.2022
CH31.08.2022
IE31.08.2022
LI31.08.2022
LU31.08.2022
Former [2023/35]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
IT09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
CH31.08.2022
IE31.08.2022
LI31.08.2022
LU31.08.2022
Former [2023/33]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
CH31.08.2022
IE31.08.2022
LI31.08.2022
LU31.08.2022
Former [2023/21]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
CH31.08.2022
LI31.08.2022
LU31.08.2022
Former [2023/16]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/10]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/01]AL09.02.2022
AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/49]AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/48]AT09.02.2022
CZ09.02.2022
DK09.02.2022
EE09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/47]AT09.02.2022
DK09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SE09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/46]AT09.02.2022
DK09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/42]AT09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/39]AT09.02.2022
ES09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/36]AT09.02.2022
ES09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
NL09.02.2022
PL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/35]ES09.02.2022
HR09.02.2022
LT09.02.2022
NL09.02.2022
RS09.02.2022
SE09.02.2022
BG09.05.2022
NO09.05.2022
PT09.06.2022
Former [2022/34]ES09.02.2022
LT09.02.2022
NL09.02.2022
NO09.05.2022
PT09.06.2022
Former [2022/33]LT09.02.2022
NO09.05.2022
Documents cited:Search[I]US2013012502  (ROSA-CALATRAVA MANUEL [FR], et al) [I] 5,8,9,14* paragraph [0017] *;
 [XI]WO2016176279  (UNIV CALIFORNIA [US]) [X] 1-4,6,7,10-13,15 * page 4, line 16 - page 10, line 2 * [I] 5,8,9,14
International search[X]CN103282021  (BIOCOPEA LTD) [X] 1-4, 6-8, 15-18, 20-22, 24, 25;
 [X]CN103391768  (BIOCOPEA LTD)[X] 1-4, 6-8, 15-18, 20-22, 24, 25
ExaminationWO2016092539
 WO2016181394
    - GORDON R ET AL, "Antitussive activity of some naturally occurring cannabinoids ins anesthetized cats", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 35, no. 2, doi:10.1016/0014-2999(76)90233-8, ISSN 0014-2999, (19760201), pages 309 - 313, (19760201), XP025575018

DOI:   http://dx.doi.org/10.1016/0014-2999(76)90233-8
by applicant   - HAY, A.J.GREGORY, VDOUGLAS, A.R.LIN, YP., "The evolution of human influenza viruses", Philosophical transactions of the Royal Society of London Series B, Biological sciences, (20010000), vol. 356, pages 1861 - 1870
    - BERNARD, G.R.LUCE, J.M.SPRUNG, C.L.RINALDO, J.E.TATE, R.M.SIBBALD, W.J.KARIMAN, K.HIGGINS, S.BRADLEY, R.METZ, C.A. et al., "High-dose corticosteroids in patients with the adult respiratory distress syndrome", The New England journal of medicine, (19870000), vol. 317, pages 1565 - 1570
    - GLEZEN, W.P., "Influenza control", The New England journal of medicine, (20060000), vol. 355, pages 79 - 81
    - KOLOCOURIS, N.KOLOCOURIS, A.FOSCOLOS, G.B.FYTAS, G.NEYTS, J.PADALKO, E.BALZARINI, J.SNOECK, R.ANDREI, G.DE CLERCQ, E., "Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives", 2. J Med Chem, (19960000), vol. 39, doi:10.1021/jm950891z, pages 3307 - 3318, XP002449961

DOI:   http://dx.doi.org/10.1021/jm950891z
    - RIBEIRO, A.ALMEIDA, VI.COSTOLA-DE-SOUZA, C.FERRAZ-DE-PAULA, V.PINHEIRO, M.L.VITORETTI, L.B.GIMENES-JUNIOR, J.A.AKAMINE, A.T.CRIPPA, J.A.TAVARES-DE-LIMA, W. et al., "Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury", Immunopharmacology and immunotoxicolog, (20150000), vol. 37, pages 35 - 41
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.